Factors Impacting Vaccine Uptake during Pregnancy: A Retrospective Analysis

Maame Aba Coleman; Deepa Dongarwar; Jessica Ramirez; Mei-Li Laracuente; Chelsea Livingston; Julliet Ogu; Racquel Lyn; Arabella Hall; Sylvia Adu-Gyamfi; Hamisu M Salihu

doi:10.21106/ijma.554

Factors Impacting Vaccine Uptake during Pregnancy: A Retrospective Analysis

Int J MCH AIDS. 2022;11(2):e554. doi: 10.21106/ijma.554. Epub 2022 Sep 7.

Authors

Affiliations

¹ Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
² Center of Excellence in Health Equity, Training and Research, Baylor College of Medicine Houston, Texas, USA.
³ Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas, USA.

Abstract

Background and objective: Vaccine uptake rates during pregnancy remain below target goals due to a convergence of factors. In particular, women of lower socioeconomic means and racial minorities typically have reduced rates of vaccine acceptance. This study aims to identify additional factors contributing to vaccine acceptance within a sample population of women receiving prenatal care in Houston, Texas, United States of America.

Methods: We performed a retrospective cross-sectional analysis of 11,500 pregnant women covered by Medicaid or ChipPerinate who received prenatal care during 2013-2021, assessing influenza (flu) and combined Tetanus, Diphtheria, Acellular Pertussis (TDAP) vaccine acceptance in the patient population. We examined temporal trends in flu and TDAP vaccination rates using Joinpoint regression analyses and evaluated the factors associated with single or concomitant vaccine acceptance during the study period and during the COVID-19 pandemic using adjusted log-binomial regression models.

Results: In our population, 54% of patients received flu vaccination, and 76.1% received TDAP. TDAP rates increased from 2013-2015 but have shown an overall decline since then, as with the flu vaccine. Earlier entry to prenatal care (Prevalence Ratio [PR] 6.32; Confidence Interval [CI] 3.28-12.24) and pregnancy comorbidity such as gestational diabetes (PR 1.32; CI 0.82-2.19) were positively associated with uptake. In contrast, the NH-Black race was negatively associated with vaccine acceptance (PR 0.51 CI; 0.25-0.99). Otherwise, age and history of pre-pregnancy comorbidities were not significant predictors.

Conclusion and global health implications: Within demographic groups identified as at-risk for vaccine refusal, modifying factors further impact vaccine hesitancy. Identifying these elements will guide targeted patient efforts to promote vaccine uptake, both for routine prenatal recommendations and for COVID vaccination.

Keywords: COVID-19; Flu; Patient Communication; TDAP; Vaccination in Pregnancy; Vaccine Hesitancy in Pregnancy.